APOL1 variant-associated kidney disease: from trypanosomes to podocyte cytoskeleton
- 1 December 2020
- journal article
- editorial
- Published by Elsevier BV in Kidney International
- Vol. 98 (6), 1373-1377
- https://doi.org/10.1016/j.kint.2020.07.034
Abstract
No abstract availableFunding Information
- European Research Council
This publication has 15 references indexed in Scilit:
- The function of apolipoproteins L (APOLs): relevance for kidney disease, neurotransmission disorders, cancer and viral infectionThe FEBS Journal, 2020
- APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of ActomyosinCell Reports, 2020
- APOL1 and Kidney Disease: From Genetics to BiologyAnnual Review of Physiology, 2020
- ATG9A shapes the forming autophagosome through Arfaptin 2 and phosphatidylinositol 4-kinase IIIβThe Journal of cell biology, 2019
- APOL1: The Balance Imposed by Infection, Selection, and Kidney DiseaseTrends in Molecular Medicine, 2018
- ApoL1 Overexpression Drives Variant-Independent CytotoxicityJournal of the American Society of Nephrology, 2017
- Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1Nature Communications, 2015
- The molecular arms race between African trypanosomes and humansNature Reviews Microbiology, 2014
- APOL1 Null Alleles from a Rural Village in India Do Not Correlate with GlomerulosclerosisPLOS ONE, 2012
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010